Clinical trial
Effect of Sodium Zirconium Cyclosilicate on Hyperkalemia After Parathyroidectomy in Secondary Hyperparathyroidism Patients With Maintenance Hemodialysis
NCT05382988 is registered in ClinicalTrials.gov with Guangdong Provincial People's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Sodium Zirconium Cyclosilicate on Hyperkalemia After Parathyroidectomy in Secondary Hyperparathyroidism Patients With Maintenance Hemodialysis
- Lead sponsor
- Guangdong Provincial People's Hospital
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- November 30, 2016
- Completion date
- December 31, 2021
- Enrollment
- 62 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
hyperkalemia, hyperparathyroidism, secondary, sodium zirconium cyclosilicate